Pulmonary Regurgitation clinical trials at UC Health

• ALTERRA: SAPIEN 3 THV With the Alterra Adaptive Prestent

  open to all eligible people

  To demonstrate the safety and effectiveness of the Edwards Alterra Adaptive Prestent in conjunction with the Edwards SAPIEN 3 Transcatheter Heart Valve (THV) System in subjects with a dysfunctional right ventricular outflow tract/pulmonary valve (RVOT/PV) who are indicated for treatment of pulmonary regurgitation (PR). Following completion of enrollment, subjects will be eligible for enrollment in the continued access phase of the trial.

  at UCLA UCSF

• The Medtronic Harmony™ Transcatheter Pulmonary Valve Clinical Study

  Sorry, in progress, not accepting new patients

  The purpose of this study is to further evaluate the safety and effectiveness of the Harmony™ TPV system.

  at UCLA

Last updated: December 23, 2020